Evidence map›Paper›PMID 27877235›Full record

ArticleTheranostics2016

X-Ray Induced Photodynamic Therapy: A Combination of Radiotherapy and Photodynamic Therapy.

Geoffrey D Wang, Ha T Nguyen, Hongmin Chen, Phillip B Cox, Lianchun Wang, Koichi Nagata, Zhonglin Hao, Andrew Wang, Zibo Li, Jin Xie

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed, 2 pooled it
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 2 syntheses or guidelines pooled it, 245 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Advancements and emerging trends in photodynamic therapy: innovations in cancer treatment and beyond.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2025
    Review
  12. Review
  13. Review
  14. Activatable Photosensitizers: From Fundamental Principles to Advanced Designs.Angewandte Chemie (International ed. in English) · 2025
    Review
  15. Article
  16. Atomically-precise AuJournal of nanobiotechnology · 2025
    Article
  17. Article
  18. Article
  19. Review
  20. Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Geoffrey D WangDepartment of Chemistry, Bio-Imaging Research Center, the University of Georgia, Athens, Georgia 30602, USA.
Ha T NguyenNational Exposure Research Lab, US Environmental Protection Agency, Athens, Georgia 30605, USA.
Hongmin ChenDepartment of Chemistry, Bio-Imaging Research Center, the University of Georgia, Athens, Georgia 30602, USA.
Phillip B CoxDepartment of Cellular Biology, the University of Georgia, Athens, Georgia 30602, USA.
Lianchun WangDepartment of Biochemistry and Molecular Biology, the University of Georgia, Athens, Georgia 30602, USA.
Koichi NagataCollege of Veterinary Medicine, The University of Georgia, Athens, GA 30602, USA.
Zhonglin HaoSection of Hematology and Oncology, Georgia Cancer Center, Medical College of Georgia, Augusta University, Augusta, Georgia 30912, USA.
Andrew WangLaboratory of Nano- and Translational Medicine, Department of Radiation Oncology, Lineberger Comprehensive Cancer Center, Carolina Center for Cancer Nanotechnology Excellence, University of North Carolina at Chapel Hill, Chapel Hill, USA.
Zibo LiDepartment of Radiology and Biomedical Research Imaging Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Jin XieDepartment of Chemistry, Bio-Imaging Research Center, the University of Georgia, Athens, Georgia 30602, USA.
University of Georgia · USUniversity of North Carolina at Chapel Hill · USAugusta University · USEnvironmental Protection Agency · US

Funding

TR&D3. Approaches to Proteoglycan Function at Biochemical and Cellular LevelsP41GM103390 · NIGMS · UNIVERSITY OF GEORGIA · PI MOREMEN, KELLEY W. · 2012 to 2019
$14.5M
Robo4 and heparan sulfate proteoglycan in angiogenesisR01HL093339 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI WANG, LIANCHUN · 2009 to 2018
$3.4M
Nanoparticle formulations of DNA repair inhibitors to improve chemoradiotherapyR01CA178748 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WANG, ANDREW ZHUANG · 2013 to 2017
$1.6M
Using CRISPR-Cas9 technology to develop a mutant cell library for heparan sulfate structure-function studyR21HL131553 · NHLBI · UNIVERSITY OF GEORGIA · PI WANG, LIANCHUN · 2015 to 2016
$582k
NCI NIH HHS R01 CA178748NHLBI NIH HHS R01 HL093339NHLBI NIH HHS R21 HL131553NIGMS NIH HHS P41 GM103390
6 · The paper itself

Abstract

Conventional photodynamic therapy (PDT)'s clinical application is limited by depth of penetration by light. To address the issue, we have recently developed X-ray induced photodynamic therapy (X-PDT) which utilizes X-ray as an energy source to activate a PDT process. In addition to breaking the shallow tissue penetration dogma, our studies found more efficient tumor cell killing with X-PDT than with radiotherapy (RT) alone. The mechanisms behind the cytotoxicity, however, have not been elucidated. In the present study, we investigate the mechanisms of action of X-PDT on cancer cells. Our results demonstrate that X-PDT is more than just a PDT derivative but is essentially a PDT and RT combination. The two modalities target different cellular components (cell membrane and DNA, respectively), leading to enhanced therapy effects. As a result, X-PDT not only reduces short-term viability of cancer cells but also their clonogenecity in the long-run. From this perspective, X-PDT can also be viewed as a unique radiosensitizing method, and as such it affords clear advantages over RT in tumor therapy, especially for radioresistant cells. This is demonstrated not only in vitro but also in vivo with H1299 tumors that were either subcutaneously inoculated or implanted into the lung of mice. These findings and advances are of great importance to the developments of X-PDT as a novel treatment modality against cancer.

Indexed as

AnimalsDisease Models, AnimalLung NeoplasmsMicePhotochemotherapyRadiotherapySmall Cell Lung CarcinomaTransplantation, HeterologousTreatment OutcomeX-Raysclonogenecitylung cancernanoparticles.photodynamic therapyradiotherapy

Identifiers

PMID27877235
PMCPMC5118595
OpenAlexW2551798103

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.